biomedicina slovenica


re="Arthritis Rheum" : 36

  1. Seror Raphaele; Theander Elke; Brun Johan G; Tomšič Matija
    Validation of EULAR primary Sjoergen's Syndrome disease activity and patient indexes
    2012
  2. Plešivčnik-Novljan Martina; Rotar Žiga; Ambrožič Aleš; Vidmar Gaj; Tomšič Matija
    Longitudinal evaluation of the performance of different classification criteria in patients with primary Sjoegren's syndrome
    2012
  3. Rotar Žiga; Hočevar Alojzija; Gašperšič Nataša; Hostnik Branka; Antolić Anita; Tomšič Matija
    Safety of minor labial salivary gland biopsy
    2012
  4. Rotar Žiga; Praprotnik Sonja; Tomšič Matija
    Clinical contrasts with the American College of Rheumatology/European League Against Rheumatism provisional definitions of remission in rheumatoid arthritis for clinical trials: comment on the article by Felson et al
    2011
  5. Shen Shiqian; Shin Junghee J; Strle Klemen; McHugh Gail; Li Xin; Glickstein Lisa J; Drouin Elise E; Steere Allen C
    Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive lyme arthritis
    2010
  6. van Vollenhoven Ronald; Chatzidionysiou K; Nasonov E; Tomšič M
    Six-month results from the collaborative European registries for rituximab in rheumatoid arthritis (CERERRA). Efficacy of rituximab is highest in RF-positive patients and in those who failed at most one prior anti-TNF
    2009
  7. Jones G; Gu JR; Lowenstein M; Calvo A; Gomez-Reino JJ; Siri D; Tomšič M; Blackburn R; Woodsworth T; Sebba A; Genovese M
    The AMBITION study: superiority of Tociluzumab (TCZ) vs Methotrexate (MTX) monotherapy in patients with rheumatoid arthritis (RA)
    2008
  8. Genovese M; Siri D; Tomšič M; Blackburn R; Woodworth T; Jones G
    Tociluzumab (TCZ) monotherapy improves rheumatoid arthritis (RA) outcomes regardless of disease duration
    2008
  9. van Vollenhoven Ronald F; Gabay Cem; Hetland Merete L; Gomez-Reino Juan J; van Riel Piet LCM; Pavelka Karel; Nordstroem Dan C; Tomšič Matija; Smolen Josef S; Kvien Tore K
    Seven-hundred and fifty patients treated with Rituximab for RA in European registries: baseline data analysis from the collaborative European registries for Rituximab in RA (CERERRA)
    2008
  10. Praprotnik S; Tomšič M
    Osteoporosis, vitamin D deficiency, and supplementation in juvenile systemic lupus erythematosus: comment on the article by Compeyrot-Lacassagne et al
    2007
  11. Avčin T; Benseler SM; Tyrrell PN; Čučnik S; Silverman ED
    A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus
    2008
  12. Karassa Fotini B; Afeltra Antonella; Ambrožič Aleš; Chang Deh-Ming; De Keyser Filip; Doria Andrea; Galeazzi Mauro; Božič Borut; Rozman Blaž
    Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis
    2006
  13. Fiore Stefano; Aloman Monica; Sodin-Šemrl Snežna; Antico Giovanni
    Amplification of serum amyloid A induced chemotaxis of human synovial fibroblasts by formation of an interleukin-8 gradient: role of CXCR8 expression in human synovial tissue
    2005
  14. Antico Giovanni; Sodin-Šemrl Snežna; Varga John; Miele Lucio; Fiore Stefano
    Uteroglobin, a novel anti-inflammatory Lipoxin A4, receptor lugand antagonizes serum amyloid A-induced release of IL-8 and chemotaxis in fibroblast-like synoviocytes
    2004
  15. Sodin-Šemrl Snežna; Varga John; Fiore Stefano
    Lipoxin A4 and serum amyloid A cause opposite effects on cell chemotaxis. Role of differential phospholipase signaling via the common receptor ALXR
    2004
  16. Barbaro Barbara; Spagnolo Alessandra; Sodin-Šemrl Snežna; Fiore Stefano; Varga John
    Peptidoleukotriene D4- and Lipoxin A4- dependent responses in HUVEC require expression of the peptidoleukotriene CysLT2 receptor: role of vitronectin and integrin signaling
    2003
  17. Sodin-Šemrl Snežna; Fiore Stefano; Antico Giovanni; Miele Lucio; Spagnolo Alessandra; Barbaro Barbara; Varga John
    Uteroglobin inhibits serum amyloid A induced interlaukin-8 and interleukin-6 levels in human fibroblast like synoviocytes
    2003
  18. Sodin-Šemrl Snežna; Fiore Stefano; Spagnolo Alessandra; Barbaro Barbara; Varga John
    Additive and synergistic mechanisms between interleukin-1beta, transforming growth factor-beta2 and serum amyloid A result in amplification of inflammatory responses in human fibroblast-like synoviocytes
    2003
  19. Fiore Stefano; Sodin-Šemrl Snežna; Spagnolo Alessandra; Mikus Raymond; Barbaro Barbara; Varga John
    Serum amyloid A (SAA) leads to activation of synovial fibroblasts: significance of NF-kB and AP-1 transcriptional complexes and the functional antagonism by lipoxin A4
    2002
  20. Fiore Stefano; Sodin-Šemrl Snežan; Spagnolo Alessandra; Mikus Raymond; Barbaro Barbara; Varga John
    Serum amyloid A and lipoxin A4 cause opposite regulation of synovial fibroblast response to apoptotic stimuli
    2002
  21. Fiore Stefano; Sodin-Šemrl Snežna; Popescu Alexandra; Varga John
    Differential signaling of Lipoxin A4 and serum amyloid A via LXA4R in human synovial fibriblasts: functional consequences on cell activation
    2001
  22. Fiore Stefano; Sodin-Šemrl Snežna; Kang Yong; Varga John
    Activation of LXA4R by Lipoxin A4 or serum amyloid A result in opposite regulation of NF-KB DNA binding in human synovial fibroblasts
    2000
  23. Fiore Stefano; Kang Yong; Sodin-Šemrl Snežna; Varga John
    Lipoxin A4 inhibits cell proliferation and promotes apoptosis in fibroblast like synoviocytes (FLS) and endothelial cells
    2000
  24. Fiore Stefano; Sodin-Šemrl Snežna; Kang Yong; Tseng Daniel; Varga John; Taddeo Brunella
    Lipoxin A4 inhibits interleukin-1beta-induced proinflammatory activation of human synovial fibroblasts
    1999
  25. Fiore Stefano; Kang Yong; Sodin-Šemrl Snežna; Varai George; Varga John; Taddeo Brunella
    Impact of selected serine, threonine and tyrosine mutations in the intracellular domains of the human lipoxin A4 receptor on desensitization and signaling
    1999
  26. Ruperto Nicolino; Ravelli Angelo; Oliveira Sheila; Alessio Maria; Mihaylova Dimitrina; Pašić Srdjan; Cortis Elisabetta; Apaz Maria; Burgos-Vargas Ruben; Avčin Tadej
    The pediatric rheumatology international trials organization/American college of rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definiton of improvement
    2006
  27. Rotar Žiga; Praprotnik Sonja; Tomšič Matija
    Concerns about the prevalence of primary Sjoegren's syndrome: comment on the article by Theander et al
    2005
  28. Vesel Samo; Mazić Uroš; Blejec Tanja; Podnar Tomaž
    First-degree heart block in the fetus of an anti-SSA/Ro-positive mother: reversal after a short course of dexamethasone treatment
    2004
  29. Plešivčnik-Novljan Martina; Rozman Blaž; Primic-Žakelj Maja; Grmek Marko; Kveder Tanja; Tomšič Matija
    Incidence of primary Sjoegren's syndrome in Slovenia
    2002
  30. Kalden JR; Schattenkirchner M; Soerensen H; Emery P; Deighton C; Rozman B; Breedveld F
    The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study
    2003
  31. Praprotnik Sonja; Blank Miri; Meroni Pier Luigi; Rozman Blaž; Eldor Amiram; Shoenfeld Yehuda
    Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications
    2001
  32. Bresnihan Barry; Alvaro-Gracia Jose Maria; Cobby Mark; Doherty Michael; Domljan Zlatko; Emery Paul; Nuki George; Pavelka Karel; Rau Rolf; Rozman Blaž
    Blindedness in clinical trials of therapies for rheumatoid arthritis: comment on the article by Bresnihan et al: reply
    1999
  33. Blank Miri; Krause Ilan; Goldkorn Tzipora; Praprotnik Sonja; Livneh Avi; Langevitz Pnina; Kaganovsky Ella; Morrgenstern Sara; Cohen Shlomo; Barak Vivian
    Monoclonal anti-endothelial cell antibodies from a patient with takayasu arteritis activate endothelial cells from large vessels
    1999
  34. Praprotnik Sonja; Tomšič Matija
    Is malignant infiltration necessary for development of leukemic arthritis? Comment on the article by Rudwaleit et al
    1999
  35. Bresnihan Barry; Alvaro-Gracia Jose Maria; Cobby Mark; Doherty Michael; Domljan Zlatko; Emery Paul; Nuki George; Pavelka Karel; Rau Rolf; Rozman Blaž
    Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
    1998
  36. Mladenović Vlastimir; Domljan Zlatko; Rozman Blaž; Jajić Ivo; Mihajlović Dimitrije; Ðorđević Jovan; Popović Milan; Dimitrijević Miroslava; Živković Milutin; Campion Giles
    Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis
    1995


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko